Zhejiang Tianxian Biopharm Co.,Ltd.is located in the scenic Yangfu Industrial Zone of Xianju. Jointly established by listed company Xianju Pharmaceutical Co., Ltd. and a professional team with years of experience in the pharmaceutical industry, the company focuses on the R&D, production, and sales of high-end biopharmaceutical products and high-end sterile active pharmaceutical ingredients (APIs), etc. The core members of the company's management team all come from pharmaceutical enterprises, with an average of more than 15 years of industry experience. This experienced and dynamic management team lays the foundation for the company's standardized management and long-term development. Adhering to the path of sustainable development driven by technological innovation, the company takes high-end non-steroidal sterile APIs and biopharmaceuticals as its development direction. Integrating R&D, production, and sales, it aims to establish a comprehensive product system and strive to become a composite high-tech industrial company covering multiple fields such as pharmaceuticals, beauty, food, and cosmetics. The company's main product is sodium hyaluronate, whose applications span food, cosmetics, medical devices, and pharmaceutical products. Committed to producing high-quality products through its unique technological processes, the company places particular emphasis on the production of high-end sterile sodium hyaluronate. In addition to independent R&D products, it maintains close cooperation with universities, research institutes, and R&D companies. In the future, the company will focus more on biopharmaceuticals, new drug synthesis processes, and sterile API products. Currently under construction, the company will have an annual production capacity of over 200 tons upon completion. Meanwhile, it has initiated the establishment of a pharmaceutical quality management system and product registration procedures. It is expected to complete product registrations with China's NMPA, the US FDA, the European EDQM, etc., and obtain relevant GMP certifications by 2026. As a new-type biopharmaceutical manufacturing enterprise, we firmly believe that professionalism and diligence can create greater value. Our vision is to become a world-class high-quality pharmaceutical company. Upholding an attitude of openness, learning, and win-win cooperation, we strive to be an angel safeguarding human health.